Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04061590
Title Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Cisplatin + Pembrolizumab + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.